Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 18;33(11):doaa022.
doi: 10.1093/dote/doaa022.

Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma

E Jezerskyte  1 , L M Saadeh  2 , E R C Hagens  1 , M A G Sprangers  3 , L Noteboom  1 , H W M van Laarhoven  4 , W J Eshuis  1 , M C C M Hulshof  5 , M I van Berge Henegouwen  1 , S S Gisbertz  1
Affiliations

Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma

E Jezerskyte et al. Dis Esophagus. .

Abstract

Introduction: Both cervical (McKeown) and intrathoracic (Ivor Lewis) anastomosis of transthoracic esophagectomy are surgical procedures that can be performed for distal esophageal or gastro-esophageal junction (GEJ) cancer. The purpose of this study was to investigate the long-term health-related quality of life (HR-QoL) after McKeown and Ivor Lewis esophagectomy in a tertiary referral center.

Methods: Disease-free patients >1 year following a McKeown or an Ivor Lewis esophagectomy with a two-field lymphadenectomy for a distal or GEJ carcinoma visiting the outpatient clinic between 2014 and 2018 were asked to complete the EORTC QLQ-C30 and EORTC QLQ-OG25 questionnaires. HR-QoL was investigated in both groups.

Results: A total of 89 patients were included after McKeown and 115 after Ivor Lewis esophagectomy. Median follow-up was 2.4 years (IQR 1.7-3.6). Patients after McKeown esophagectomy reported more problems with 'eating with others' compared to patients after Ivor Lewis esophagectomy (mean scores: 49.9 vs. 38.8). This difference was both clinically relevant and significant after correction for multiple testing (β = 11.1, 95% CI 3.105-19.127, P = 0.042). Patients in both groups reported a poorer HR-QoL (≥10 points) than the general population with respect to nausea and vomiting, dyspnea, appetite loss, financial difficulties, problems with eating, reflux, eating with others, choked when swallowing, trouble with coughing, and weight loss.

Conclusion: Long-term HR-QoL of disease-free patients following a McKeown or Ivor Lewis esophagectomy for a distal or GEJ carcinoma is largely comparable. Irrespective of the surgical technique, patients' HR-QoL following esophagectomy is compromised. When given the choice, patients should be informed that after a McKeown esophagectomy more problems while eating with others can occur.

Keywords: esophageal neoplasms; esophagectomy; postoperative complications; quality of life.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow chart 104 × 82 mm (300 × 300 DPI).
See this image and copyright information in PMC

References

    1. DICA Annual Report of the Dutch Upper Gastrointestinal Cancer Audit. Dutch Institute for Clinical Auditing 2019. Available from https://dica.nl/jaarrapportage-2018/duca.
    1. Smyth E C, Lagergren J, Fitzgerald R C et al. Oesophageal cancer. Nat Rev Dis Primers 2017; 3: 17048–8. - PMC - PubMed
    1. Zhang Y, Yang X, Geng D, Duan Y, Fu J. The change of health-related quality of life after minimally invasive esophagectomy for esophageal cancer: a meta-analysis. World J Surg Oncol 2018; 16: 97. - PMC - PubMed
    1. Egberts J H, Schniewind B, Bestmann B et al. Impact of the site of anastomosis after oncologic esophagectomy on quality of life—a prospective, longitudinal outcome study. Ann Surg Oncol 2008; 15: 566–75. - PubMed
    1. Deng J, Su Q, Ren Z et al. Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis. Onco Targets Ther 2018; 11: 6057–69. - PMC - PubMed